apocell Home Contact Us
  • CLINICAL TRIAL EXPERIENCE
    120
    SPECIMENS ANALYZED
    53,478
  • proposal request contact us

  • News

    February 4, 2010

    ApoCell Awarded Contract to Develop Circulating Tumor Cell Isolation Technology (ApoStreamTM) from NCI's Division of Cancer Treatment and Diagnosis (DCTD)

    June 1, 2011, Houston

    ApoCell Launches Revolutionary Circulating Cancer Cell Detection System - ApoStreamTM

    August 10, 2011, Houston

    ApoCell Awarded $2.9M from SAIC-Frederick, Inc. to Deliver a New Platform for Detection and Molecular Analysis of Circulating Tumor Cells

    August 24, 2011, Houston

    ApoCell named to Inc Magazine's List of the 5000 Fastest Growing Private Companies

    September 23, 2011, Houston

    ApoCell named to Houston Business Journal's List of the 100 Fastest-Growing Private Companies in Houston

    September 30, 2011, Houston

    ApoCell awarded SBIR Grant to Develop Point of Care Device for Antibody Independent Isolation of Circulating Tumor Cells

  • Conferences

  • Publications

    antiangiogenic cancer therapy
Pharmacodynamics

Pharmacodynamics

Phosphorylated proteins, angiogenesis, apoptosis, DNA repair, pathway-resistance markers, tissues, CTCs, CECs, surrogate specimens

 Molecular Analysis

Molecular Analysis

Single cell nucleic acid-based analysis, genetic mutations, amplification, and translocations, FISH, gene expression
Clinical Assay Development

Clinical Assay Development

Multiplex assays, validated biomarkers, translational research studies, proof of concept, biomarker screening, integrated platform technologies

 Multiplex Flow Cytometry

Multiplex Flow Cytometry

Multi-fluororchrome panels, rare cell detection, pharmacodynamic analysis, enumeration and phenotyping following enrichment
Rare Cell Analysis

Circulating Tumor Cells

CTCs, CECs, stem cells, circulating endothelial progenitor cells (CEPs), and custom isolation of rare cells

 Rare Cell Analysis

ApoStreamTM Technology

Antibody-independent, viable CTCs from various cancers, high recovery, and low starting volume
Validated Biomarkers

Validated Biomarkers

Apoptosis, AKT, EGF, VEGF, P53, DNA repair
home | contact  | sitemap
Copyright © 2009-2011 ApoCell. All rights reserved.